BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 17973540)

  • 1. Drug-induced skin, nail and hair disorders.
    Valeyrie-Allanore L; Sassolas B; Roujeau JC
    Drug Saf; 2007; 30(11):1011-30. PubMed ID: 17973540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse drug reactions and organ damage: The skin.
    Marzano AV; Borghi A; Cugno M
    Eur J Intern Med; 2016 Mar; 28():17-24. PubMed ID: 26674736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug eruptions: approaching the diagnosis of drug-induced skin diseases.
    Nigen S; Knowles SR; Shear NH
    J Drugs Dermatol; 2003 Jun; 2(3):278-99. PubMed ID: 12848112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Annular drug eruptions.
    Wu WH; Chu CY
    Clin Dermatol; 2022; 40(5):450-465. PubMed ID: 34979270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse cutaneous drug eruptions: current understanding.
    Hoetzenecker W; Nägeli M; Mehra ET; Jensen AN; Saulite I; Schmid-Grendelmeier P; Guenova E; Cozzio A; French LE
    Semin Immunopathol; 2016 Jan; 38(1):75-86. PubMed ID: 26553194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical overview: adverse cutaneous reactions to psychotropic medications.
    Kimyai-Asadi A; Harris JC; Nousari HC
    J Clin Psychiatry; 1999 Oct; 60(10):714-25; quiz 726. PubMed ID: 10549695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification and management of skin, hair, nail and mucosal side-effects of epidermal growth factor receptor (EGFR) inhibitors.
    Galimont-Collen AF; Vos LE; Lavrijsen AP; Ouwerkerk J; Gelderblom H
    Eur J Cancer; 2007 Mar; 43(5):845-51. PubMed ID: 17289377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug reactions affecting hair and nails.
    Wollina U; Abdel-Naser MB
    Clin Dermatol; 2020; 38(6):693-701. PubMed ID: 33341202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous drug eruptions associated with the use of biologies and cutaneous drug eruptions mimicking specific skin diseases.
    Seneschal J; Milpied B; Taieb A
    Chem Immunol Allergy; 2012; 97():203-16. PubMed ID: 22613864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe Cutaneous Adverse Drug Reactions: Presentation, Risk Factors, and Management.
    Mustafa SS; Ostrov D; Yerly D
    Curr Allergy Asthma Rep; 2018 Mar; 18(4):26. PubMed ID: 29574562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of osteoporosis: recognizing and managing cutaneous adverse reactions and drug-induced hypersensitivity.
    Musette P; Brandi ML; Cacoub P; Kaufman JM; Rizzoli R; Reginster JY
    Osteoporos Int; 2010 May; 21(5):723-32. PubMed ID: 19921087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clindamycin-induced Maculopapular Exanthema with Preferential Involvement of Striae Distensae: A Koebner phenomenon?
    Monteagudo B; Cabanillas M; Iriarte P; Ramírez-Santos A; León-Muinos E; González-Vilas D; Suárez-Amor Ó
    Acta Dermatovenerol Croat; 2018 Apr; 26(1):61-63. PubMed ID: 29782303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential diagnosis of severe cutaneous drug eruptions.
    Bachot N; Roujeau JC
    Am J Clin Dermatol; 2003; 4(8):561-72. PubMed ID: 12862499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognition and management of severe cutaneous drug reactions.
    Knowles SR; Shear NH
    Dermatol Clin; 2007 Apr; 25(2):245-53, viii. PubMed ID: 17430761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse Skin Reactions with Antiepileptic Drugs Using Korea Adverse Event Reporting System Database, 2008-2017.
    Kim HK; Kim DY; Bae EK; Kim DW
    J Korean Med Sci; 2020 Feb; 35(4):e17. PubMed ID: 31997613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cutaneous adverse drug reactions].
    Lebrun-Vignes B; Valeyrie-Allanore L
    Rev Med Interne; 2015 Apr; 36(4):256-70. PubMed ID: 25458866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe drug-induced skin reactions: clinical pattern, diagnostics and therapy.
    Mockenhaupt M
    J Dtsch Dermatol Ges; 2009 Feb; 7(2):142-60; quiz 161-2. PubMed ID: 19371237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Phenotypes of Severe Cutaneous Drug Hypersensitivity Reactions.
    Guvenir H; Arikoglu T; Vezir E; Misirlioglu ED
    Curr Pharm Des; 2019; 25(36):3840-3854. PubMed ID: 31696807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Perspectives on Severe Drug Eruption.
    Zhang J; Lei Z; Xu C; Zhao J; Kang X
    Clin Rev Allergy Immunol; 2021 Dec; 61(3):282-298. PubMed ID: 34273058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DRESS syndrome with mild manifestations as a diagnostic and therapeutic problem: case report.
    Artuković M; Kustelega J; Lugović-Mihić L
    Acta Clin Croat; 2010 Dec; 49(4):479-84. PubMed ID: 21830461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.